Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | TSHR | P16473 | 4/20 | 0.60 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | SI | P14410 | 1/20 | 0.42 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | KDM5A | P29375 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12791521 | 1.00 | KMT2A (0.62) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL2055295 | 1.00 | KMT2A (0.62) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL2055303 | 1.00 | KMT2A (0.62) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL64783 | 0.97 | KMT2A (0.65) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL12450195 | 0.93 | KMT2A (0.56) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL16358474 | 0.93 | TSHR (0.58) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL2055304 | 0.93 | KMT2A (0.56) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL24727471 | 0.91 | KMT2A (0.54) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL15781680 | 0.91 | KMT2A (0.72) | KMT2AMEN1TSHRLMNACA12 | |
| SCHEMBL14128878 | 0.91 | KMT2A (0.54) | KMT2AMEN1TSHRLMNACA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4721762-A2 | MODIFIED POLYAMINE POLYMERS FOR DELIVERY OF BIOMOLECULES INTO CELLS | Promega Corporation (US) | 2026-04-08 | — | — | EP | disclosed |
| US-12031162-B2 | Methods and compositions for modulating a genome | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2024-07-09 | — | — | US | disclosed |
| US-12031162-B2 | Methods and compositions for modulating a genome | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2024-07-09 | — | — | US | disclosed |
| US-12024728-B2 | Methods and compositions for modulating a genome | FLAGSHIP PIONEERING INNOVATIONS VI, LLC (US) | 2024-07-02 | — | — | US | disclosed |
| US-20230301948-A1 | REDUCTION OF VIRAL INFECTIONS | PHOXBIO LIMITED (IE) | 2023-09-28 | — | — | US | disclosed |
| US-20230255999-A1 | DNA COMPOSITIONS AND RELATED METHODS | FLAGSHIP PIONEERING INNOVATIONS VII, LLC | 2023-08-17 | — | — | US | disclosed |
| US-20230242899-A1 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | TESSERA THERAPEUTICS, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230242899-A1 | METHODS AND COMPOSITIONS FOR MODULATING A GENOME | TESSERA THERAPEUTICS, INC. | 2023-08-03 | — | — | US | disclosed |
| US-20230235358-A1 | HOST DEFENSE SUPPRESSING METHODS AND COMPOSITIONS FOR MODULATING A GENOME | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2023-07-27 | — | — | US | disclosed |
| US-20230235358-A1 | HOST DEFENSE SUPPRESSING METHODS AND COMPOSITIONS FOR MODULATING A GENOME | FLAGSHIP PIONEERING INNOVATIONS VI, LLC | 2023-07-27 | — | — | US | disclosed |
| EP-1058715-B1 | FAST DRYING JET INK COMPOSITION | VIDEOJET TECHNOLOGIES INC (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-1422275-A1 | Fast drying jet ink composition | Videojet Technologies Inc. (US) | 2004-05-26 | — | — | EP | disclosed |
| EP-0997507-B1 | New ink compositions for ink jet printing | AGFA GEVAERT (BE) | 2004-05-06 | — | — | EP | disclosed |
| EP-1344805-A1 | New ink compositions for ink jet printing | Agfa-Gevaert (BE) | 2003-09-17 | — | — | EP | disclosed |
| US-6310115-B1 | ULTRAVIOLET CURABLE INK CONSISTS OF A COPOLYMER OF ACRYLIC MONOMER AND VINYL ETHER MONOMERS; AND A COLORANT | AGFA-GEVAERT (BE) | 2001-10-30 | — | — | US | disclosed |
| US-6300388-B1 | RADIATION CURABLE | AGFA-GEVAERT (BE) | 2001-10-09 | — | — | US | disclosed |
| US-6221933-B1 | BLEND OF SOLVENT, COLORANT, POLYAMINE AND ACIDIC RESIN | MARCONI DATA SYSTEMS INC. | 2001-04-24 | — | — | US | disclosed |
| EP-0997507-A1 | New ink compositions for ink jet printing | AGFA-GEVAERT N.V. (BE) | 2000-05-03 | — | — | EP | disclosed |
| EP-0997508-A1 | New ink compositions for ink jet printing | Agfa-Gevaert naamloze vennootschap (BE) | 2000-05-03 | — | — | EP | disclosed |
| US-5596027-A | CARRIER, POLYAMINE, COLORANT, ACIDIC RESIN | VIDEOJET SYSTEMS INTERNATIONAL, INC. (US) | 1997-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230255999-A1 | DNA COMPOSITIONS AND RELATED METHODS | STING1, DNA2, TLR9 | KMT2A 2497/4885MEN1 2628/4885TSHR 2302/4885 |
| US-20230301948-A1 | REDUCTION OF VIRAL INFECTIONS | SARS1, IL36G, STING1 | KMT2A 3585/4885MEN1 3775/4885TSHR 4672/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.